Conquering Complexity: The ongoing revolution in oncology biomarker testing

The clinical management of cancer patients has undergone a remarkable evolution in the last 15 years, with the concept of personalised medicine now well-entrenched in the treatment paradigm.

Conquering complexity | IpsosWe are also in the midst of much more radical revolution, however. The molecular diagnostics landscape – and the very way we think about fighting cancer – is set to change dramatically in the coming decades.

In this update of our 2017 edition of this paper, we combine new data from Ipsos’ Global Molecular Diagnostics Monitors with our current therapy expertise and market insight to outline key developments in the oncology diagnostics landscape, and the resulting impact on cancer treatment.

We also offer a forward-looking perspective on how we believe this landscape will shift, and how today’s touchpoints may look very different in years to come.

Download the full paper here.

 

In our accompanying podcast, the author, Pieter De Richter, talks us through the paper, offering his expert perspective on the future of oncology diagnostics.

The author(s)

  • Pieter De Richter
    Pieter De Richter
    Regional Service Line Leader, Healthcare in APAC, Malaysia

More insights about Health

Related news

  • The Human Advantage Conference 2026: Highlights

    The Human Advantage Conference 2026: Highlights

    Ipsos is proud to support The Human Advantage 2026, a flagship event bringing together some of the world's leading experts and key industry figures to explore how behavioural science, AI, and human intelligence can address the critical challenges facing businesses and society. Here's a look back at two days of live coverage.
  • [WEBINAR] KEYS: Dialling Up the S In Sustainability
    KEYS Events replay

    [REPLAY] KEYS: Dialling Up the S In Sustainability

    In the next episode of our KEYS webinar, we’ll be asking whether now is the time when organisations should be ‘dialling up the S’ in their sustainability initiatives.
  • [Webinar] Real-World Evidence: Empowering the Patient
    Healthcare Webinar

    [Replay] Real-World Evidence: Empowering the Patient

    Patient voices are now central to regulatory, HTA and commercial decisions. But how do we move beyond tick-box engagement to evidence that truly reflects lived experience? Join our expert panel for a 360° perspective on making patient-centricity work in practice.